Zotefoams plc

Zotefoams plc, established in 1921 and headquartered in Croydon, UK, is a global leader in the manufacturing, distribution, and sale of polyolefin block foams. The company serves markets across the United Kingdom, Continental Europe, North America, and other international regions, structured around its Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. Its product portfolio encompasses the AZOTE range of polyolefin foams, known by brands such as Plastazote, Evazote, and Supazote. Furthermore, Zotefoams develops high-performance foams under the ZOTEK brand, which are formulated from advanced materials including fluoropolymers, engineering polymers, and specialized elastomers. The company also supplies T-FIT, a sophisticated clean insulation solution vital for pharmaceutical, biotech, and semiconductor cleanroom applications. Beyond its product lines, Zotefoams possesses and licenses the patented MuCell microcellular foam technology, complementing this with the sale of related machinery. These diverse offerings are utilized across a broad spectrum of industries, notably automotive, aerospace, product protection, industrial parts, marine, building and construction, military, and sports and leisure.

Zotefoams plc trades as ZTF.L on LSE. The company is classified in Basic Materials / Chemicals - Specialty and reports in GBP.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £158.49M of revenue and £22.64M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Zotefoams plc can be compared against peers such as Anglo Asian Mining PLC, AltynGold plc, Capital Limited, Ecora Royalties PLC, Essentra plc, Kenmare Resources plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £214.43M, beta of 1.24, and return on equity of +17.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ZTF.L currently shows total debt of £57.01M and beta of 1.24. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.zotefoams.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.